This eBook 'Frontiers in Clinical Drug Research -- Alzheimer disorders -- vol 8' is edited by Dr. Atta-ur-Rahman, published on March 4, 2019.
The book series, now in its eighth volume under the editorship of Dr. Atta-ur-Rahman is a collection of six reviews written by Alzheimer's disease experts around the world (viz Turkey, Italy, Portugal, Romania, China and Egypt). The reviews in this volume cover information about new and current drugs used for Alzheimer's disease therapy. These include general new drugs, antibiotics, antipsychotics as well as agents that target tau proteins. The volume concludes in a discussion of biological agents that can be used for prophylaxis against late onset neurodegeneration encountered in the disease. The volume is essential reading for pharmacologists, clinicians and health care workers involved in pre-clinical and clinical research on Alzheimer's disease diagnosis and therapy.
About the Author:
Prof. Dr. Atta-ur-Rahman
Prof. Dr. Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has over 1080 international publications in several fields of organic chemistry including 751 research publications, 37 international patents, 69 chapters in books and 222 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products, Studies in Natural Product Chemistry, 54 volumes of which have been published under his Editorship by Elsevier during the last two decades.
Keywords: Alzheimer's disease, Mitochondrial Complexes Tauopathy, PERK, mTOR, Aβ Amyloid Plaques, Tacrine, Neurodegenerative Disease, Multi-Functional Drugs, AChE Inhibitors, Cholinergic Hypothesis, Galantamine, Cognitive Impairment, Psychiatric Disturbances, Azithromycin, Neuroprotection, Amphotericin B, Minocycline, Rifampicin, Dapsone.